NICE to Recommend Eli Lilly’s Obesity Drug Mounjaro for NHS Use
The UK’s National Institute for Health and Care Excellence (NICE) announced on Thursday that it plans to recommend Eli Lilly’s obesity drug Mounjaro for use through...
The UK’s National Institute for Health and Care Excellence (NICE) announced on Thursday that it plans to recommend Eli Lilly’s obesity drug Mounjaro for use through...
Novo Nordisk’s Indian team is urging the Danish pharmaceutical company to expedite the launch of its weight-loss drug Wegovy to counter Eli Lilly’s upcoming rival product,...
Lilly’s Breakthrough in Cholesterol Treatment Eli Lilly’s experimental oral medication, muvalaplin, has shown significant promise in treating an inherited form of high cholesterol, specifically targeting lipoprotein(a),...